PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
ConditionLymphoma
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSherief Abd-Elsalam
About this trial
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Eligibility criteria
Qualifiers
DLBCL Lymphoma subtype --No comorbid disease
Disqualifiers
Pregnancy
Peptic ulcer
Severe cardiac disease
Osteoporosis
Trial design
Treatments tested in this trial
- CHOP
- CHOP Plus Lanzoprazole
- CHOP Plus Famotidine
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov